CCL3 and COVID-19: We found that alveolar type II (AT2) cells represent a central susceptibility hub for asthma, COPD, and COVID-19, whereas disease-specific risk enrichment was observed in subpopulations such as CCL3+ alveolar macrophages in COVID-19 and adventitial fibroblasts in asthma.